Titan Medical Inc (TMDIF)

[66Mustang]

I see it...

"we expect to prepare our regulatory submissions in the U.S. and Europe and to submit 510(k) and CE Mark applications before the end of 2018."

ex·pect - Regard (something) as likely to happen. Used to indicate that one supposes something to be so, but has no firm evidence or knowledge.
Synonyms: anticipate, await, hope (for), watch (for).


Doesn't sound like a guarantee to me, just sharing what the plans were at that time (Nov 13, 2017). Over two weeks later, the short form prospectus was released (Nov 30, 2017) likewise indicating the same expectation, with additional details on the uncertainties which could have, and ultimately did, affect the schedule. It was all there for anyone who chose to read it all instead of cherry-pick a key date from the text and consider it gospel without regard to all the info which was presented at that time. You may recall I was concerned about a full and accurate quote to ensure proper context could be derived.

They didn't know the FDA would come back and say they need more clinical trials than those written into the original plan. But they knew it was possible and publicly made allowances for that possibility.

It was not a lie merely because it was not what you want to hear. It was not a lie at all. I will re-assert that those here who have such strong distrust for the company and the management team probably shouldn't be here at all, and certainly shouldn't be poking around LinkedIn to "Like" posts which call our system a piece of crap by someone who is so heavily invested in ISRG. If a surgeon who used it called it a piece of crap, they would at least have some credibility. It turns out that any surgeon who has used it thus far has had very positive overall feedback and actual hands-on experience from which to derive a valid opinion. Or else they also all must be lying because they are saying things you don't want to believe.

If you are going to re-post that daily, be sure to include the full quote so people can know what he really said.

Message in reply to:

Titan Medical's (TITXF) CEO David McNally on Q3 2017 Results - Earnings Call Transcript $TITXFhttp://www.seekingalpha.com/article/4124481

There is a consistent pattern of findings already emerging from our preclinical studies. First, we're being told by experienced robotic surgeons that the user requirements which we finalize in a milestone earlier this year are right on target. These surgeons are telling us that the system is useful in its present form as they've been able to perform the basic functions of surgery, including tissue manipulation and approximation, grasping, cutting, suturing, and coagulation with our advanced prototypes.

Throughout the year, we will continue to refine the system to optimize performance and manufacturability. And most significantly, we expect to prepare our regulatory submissions in the U.S. and Europe and to submit 510(k) and CE Mark applications before the end of 2018.